Multiparametric PET and MRI of Myocardial Damage After Myocardial Infarction: Correlation of Integrin αvβ3 Expression and Myocardial Blood Flow

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2020 Sep 24

PMID 32970218

Citations 20

Authors

Marcus R Makowski

Christoph Rischpler

Ullrich Ebersberger

Alexandra Keithahn

Markus Kasel

Ellen Hoffmann

Tienush Rassaf

Horst Kessler

Hans-Jurgen Wester

Stephan G Nekolla

Markus Schwaiger

Ambros J Beer

Affiliations

Soon will be listed here.

Abstract

Purpose: Increased angiogenesis after myocardial infarction is considered an important favorable prognostic parameter. The αvβ3 integrin is a key mediator of cell-cell and cell-matrix interactions and an important molecular target for imaging of neovasculature and repair processes after MI. Thus, imaging of αvβ3 expression might provide a novel biomarker for assessment of myocardial angiogenesis as a prognostic marker of left ventricular remodeling after MI. Currently, there is limited data available regarding the association of myocardial blood flow and αvβ3 integrin expression after myocardial infarction in humans.

Methods: Twelve patients were examined 31 ± 14 days after MI with PET/CT using [F]Galacto-RGD and [N]NH and with cardiac MRI including late enhancement on the same day. Normal myocardium (remote) and areas of infarction (lesion) were identified on the [F]Galacto-RGD PET/CT images by correlation with [N]NH PET and cardiac MRI. Lesion/liver-, lesion/blood-, and lesion/remote ratios were calculated. Blood flow and [F]Galacto-RGD uptake were quantified and correlated for each myocardial segment (AHA 17-segment model).

Results: In 5 patients, increased [F]Galacto-RGD uptake was notable within or adjacent to the infarction areas with a lesion/remote ratio of 46% (26-83%; lesion/blood 1.15 ± 0.06; lesion/liver 0.61 ± 0.18). [F]Galacto-RGD uptake correlated significantly with infarct size (R = 0.73; p = 0.016). Moreover, it correlated significantly with restricted blood flow for all myocardial segments (R = - 0.39; p < 0.0001) and even stronger in severely hypoperfused areas (R = - 0.75; p < 0.0001).

Conclusion: [F]Galacto-RGD PET/CT allows the visualization and quantification of myocardial αvβ3 expression as a key player in angiogenesis in a subset of patients after MI. αvβ3 expression was more pronounced in patients with larger infarcts and was generally more intense but not restricted to areas with more impaired blood flow, proving that tracer uptake was largely independent of unspecific perfusion effects. Based on these promising results, larger prospective studies are warranted to evaluate the potential of αvβ3 imaging for assessment of myocardial angiogenesis and prediction of ventricular remodeling.

Citing Articles

Interaction of integrin αβ and fibronectin under fluid shear forces: implications for tumor cell adhesion and migration.

Zhuo P, Li Q, Yang B, Li N, Luo Z, Zhang F Front Cell Dev Biol. 2025; 13:1512672.

PMID: 40070879 PMC: 11894259. DOI: 10.3389/fcell.2025.1512672.

Recent advances in positron emission tomography for detecting early fibrosis after myocardial infarction.

Wu Q, Song J, Liu W, Li L, Li S Front Cardiovasc Med. 2024; 11:1479777.

PMID: 39529975 PMC: 11552091. DOI: 10.3389/fcvm.2024.1479777.

Positron emission tomography probes for stem cell monitoring: a review.

Xu L, Shi J, Wu S Am J Transl Res. 2024; 16(8):3534-3544.

PMID: 39262689 PMC: 11384350. DOI: 10.62347/CIUT6327.

Noninvasive Evaluation of Angiogenesis and Therapeutic Response after Hindlimb Ischemia with an Integrin-Targeted Tracer by PET.

Sun Z, He W, Xia S, Tong G, Zeng L, Xue L Rev Cardiovasc Med. 2024; 23(12):408.

PMID: 39076662 PMC: 11270400. DOI: 10.31083/j.rcm2312408.

Natural History of Myocardial αβ Integrin Expression After Acute Myocardial Infarction: Correlation with Changes in Myocardial Blood Flow.

Dietz M, Kamani C, Bousige C, Dunet V, Delage J, Rubimbura V J Nucl Med. 2024; 65(7):1107-1112.

PMID: 38724280 PMC: 11218729. DOI: 10.2967/jnumed.124.267514.

References

Beer A, Niemeyer M, Carlsen J, Sarbia M, Nahrig J, Watzlowik P . Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET. J Nucl Med. 2008; 49(2):255-9. DOI: 10.2967/jnumed.107.045526. View

Dobrucki L, Tsutsumi Y, Kalinowski L, Dean J, Gavin M, Sen S . Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging. J Mol Cell Cardiol. 2009; 48(6):1071-9. PMC: 2866767. DOI: 10.1016/j.yjmcc.2009.10.008. View

Laitinen I, Notni J, Pohle K, Rudelius M, Farrell E, Nekolla S . Comparison of cyclic RGD peptides for αvβ3 integrin detection in a rat model of myocardial infarction. EJNMMI Res. 2013; 3(1):38. PMC: 3658936. DOI: 10.1186/2191-219X-3-38. View

Cai M, Ren L, Yin X, Guo Z, Li Y, He T . PET monitoring angiogenesis of infarcted myocardium after treatment with vascular endothelial growth factor and bone marrow mesenchymal stem cells. Amino Acids. 2015; 48(3):811-820. DOI: 10.1007/s00726-015-2129-4. View

Notni J, Pohle K, Wester H . Be spoilt for choice with radiolabelled RGD peptides: preclinical evaluation of ⁶⁸Ga-TRAP(RGD)₃. Nucl Med Biol. 2012; 40(1):33-41. DOI: 10.1016/j.nucmedbio.2012.08.006. View

Nekolla S, Miethaner C, Nguyen N, Ziegler S, Schwaiger M . Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography. Eur J Nucl Med. 1998; 25(9):1313-21. DOI: 10.1007/s002590050301. View

Gronman M, Tarkia M, Kiviniemi T, Halonen P, Kuivanen A, Savunen T . Imaging of αβ integrin expression in experimental myocardial ischemia with [Ga]NODAGA-RGD positron emission tomography. J Transl Med. 2017; 15(1):144. PMC: 5477135. DOI: 10.1186/s12967-017-1245-1. View

Rischpler C, Nekolla S, Dregely I, Schwaiger M . Hybrid PET/MR imaging of the heart: potential, initial experiences, and future prospects. J Nucl Med. 2013; 54(3):402-15. DOI: 10.2967/jnumed.112.105353. View

Higuchi T, Bengel F, Seidl S, Watzlowik P, Kessler H, Hegenloh R . Assessment of alphavbeta3 integrin expression after myocardial infarction by positron emission tomography. Cardiovasc Res. 2008; 78(2):395-403. DOI: 10.1093/cvr/cvn033. View

10.

Simons M, Annex B, Laham R, Kleiman N, Henry T, Dauerman H . Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 2002; 105(7):788-93. DOI: 10.1161/hc0802.104407. View

11.

Mauriello A, Sangiorgi G, Fratoni S, Palmieri G, Bonanno E, Anemona L . Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol. 2005; 45(10):1585-93. DOI: 10.1016/j.jacc.2005.01.054. View

12.

Beer A, Haubner R, Goebel M, Luderschmidt S, Spilker M, Wester H . Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients. J Nucl Med. 2005; 46(8):1333-41. View

13.

Varner J, Cheresh D . Tumor angiogenesis and the role of vascular cell integrin alphavbeta3. Important Adv Oncol. 1996; :69-87. View

14.

Sun Y, Zeng Y, Zhu Y, Feng F, Xu W, Wu C . Application of (68)Ga-PRGD2 PET/CT for αvβ3-integrin imaging of myocardial infarction and stroke. Theranostics. 2014; 4(8):778-86. PMC: 4063976. DOI: 10.7150/thno.8809. View

15.

Verjans J, Wolters S, Laufer W, Schellings M, Lax M, Lovhaug D . Early molecular imaging of interstitial changes in patients after myocardial infarction: comparison with delayed contrast-enhanced magnetic resonance imaging. J Nucl Cardiol. 2010; 17(6):1065-72. PMC: 2990010. DOI: 10.1007/s12350-010-9268-5. View

16.

Beer A, Grosu A, Carlsen J, Kolk A, Sarbia M, Stangier I . [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res. 2007; 13(22 Pt 1):6610-6. DOI: 10.1158/1078-0432.CCR-07-0528. View

17.

van den Borne S, Isobe S, Verjans J, Petrov A, Lovhaug D, Li P . Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol. 2008; 52(24):2017-28. DOI: 10.1016/j.jacc.2008.07.067. View

18.

Haubner R, Kuhnast B, Mang C, Weber W, Kessler H, Wester H . [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. Bioconjug Chem. 2004; 15(1):61-9. DOI: 10.1021/bc034170n. View

19.

Naghavi M, Libby P, Falk E, Casscells S, Litovsky S, Rumberger J . From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003; 108(14):1664-72. DOI: 10.1161/01.CIR.0000087480.94275.97. View

20.

Thumshirn G, Hersel U, Goodman S, Kessler H . Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation. Chemistry. 2003; 9(12):2717-25. DOI: 10.1002/chem.200204304. View